ImmunityBio, Inc. (IBRX)

NASDAQ: IBRX · Real-Time Price · USD

2.700

-0.090 (-3.23%)

Jun 27, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2019 - 2020
Other	563.00K	Log In	Log In	Log In	Log In	Upgrade
Other Growth	86.42%	Log In	Log In	Log In	Log In	Upgrade
Product	30.66M	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2018 - 2019
United States	Log In	Log In	Log In	Log In	Upgrade
United States Growth	Log In	Log In	Log In	Log In	Upgrade
Europe	Log In	Log In	Log In	Log In	Upgrade
Europe Growth	Log In	Log In	Log In	Log In	Upgrade